Blincyto

Company:
Amgen Ireland Ltd
Status:
No Recent Update
Legal Category:
Product subject to medical prescription which may not be renewed (A)
Active Ingredient(s):
Blinatumomab
This medicinal product is subject to additional monitoring.
*Additional information is available within the SPC or upon request to the company

Licence number

Strength

ATC code

Dosage form

EU/1/15/1047/001

12.5 microgram(s)/millil itre

L01XC19

Pdr/Conc/Soln for Infusion